Bleomycin-induced alveolitis detected by FDG positron emission tomography

Clinical Nuclear Medicine

Volumn 27, Issue 7, 2002, Pages 522-523

  Hain, Sharon F ^a   Beggs, Andrew D ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Bleomycin Toxicity; FDG PET; Lymphoma

Indexed keywords

BLEOMYCIN;

ADULT; AGED; ARTICLE; CASE REPORT; HUMAN; LUNG ALVEOLITIS; LYMPHOMA; POSITRON EMISSION TOMOGRAPHY; RISK FACTOR; THORAX RADIOGRAPHY;

ADULT; AGED; BLEOMYCIN; FLUORODEOXYGLUCOSE F18; HODGKIN DISEASE; HUMANS; PULMONARY FIBROSIS; RADIOPHARMACEUTICALS;

EID: 0036661121     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-200207000-00013     Document Type: Article

References (6)

1. Hirsch A, Els NV, Strus DJ, et al: Effect of ABVD chemotherapy with and without mantle or mediastinal irradiation on pulmonary function and symptoms in early stage Hodgkin's disease. J Clin Oncol 14:1297, 1996.
2. Horowitz AL, Freidman M, Smith J, et al: The pulmonary changes of bleomycin toxicity. Radiology 106:65, 1973.
3. Bellamy EA, Husband JE, Blaquiere RM, et al: Bleomycin-related lung damage CT evidence. Radiology 106:65, 1973.
4. Pantin CF, Valind SO, Sweatman M, et al: Measures of inflammatory response in cryptogenic fibrosing alveolitis. Am Rev Respir Dis 138:1234, 1988.
5. Brown WG, Hasan FM, Barbee RA: Reversibility of severe bleomycin induced pulmonary pneumonitis. JAMA 239:2012, 1978.
6. Bakheet SM, Powe J: Benign causes of 18-FDG uptake on whole body imaging. Semin Nucl Med 28:352, 1998.